Determinants of unsuccessful tuberculosis treatment outcomes in Malaysian HIV-infected patients

Preventive Medicine

Volumn 57, Issue SUPPL, 2013, Pages

  Ismail, Ismawati ^a,b   Bulgiba, Awang ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b MINISTRY OF HEALTH   (Malaysia)

Author keywords

HIV; Prognosis; Treatment outcome; Tuberculosis

Indexed keywords

ALBUMIN;

ADULT; ALBUMIN BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; BLOOD TRANSFUSION; CHINESE; DEATH; DISEASE TRANSMISSION; DRUG TREATMENT FAILURE; EMPLOYMENT; EXTRAPULMONARY TUBERCULOSIS; FEMALE; FOLLOW UP; HETEROSEXUALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INDIAN; INTRAVENOUS DRUG ABUSE; LUNG TUBERCULOSIS; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALAYSIA; MALE; MEDICAL RECORD REVIEW; MIXED INFECTION; NUTRITIONAL STATUS; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; TREATMENT OUTCOME;

HIV; PROGNOSIS; TREATMENT OUTCOME; TUBERCULOSIS;

ADULT; ANTI-HIV AGENTS; FEMALE; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; LYMPHATIC DISEASES; MALAYSIA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SERUM ALBUMIN; SUBSTANCE ABUSE, INTRAVENOUS; TREATMENT FAILURE; TUBERCULOSIS, PULMONARY;

EID: 84880628947     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2012.12.023     Document Type: Article

References (20)

1. Anunnatsiri S., Chetchotisakd P., Wanke C. Factors associated with treatment outcomes in pulmonary tuberculosis in northeastern Thailand. Southeast Asian J. Trop. Med. Public Health 2005, 36:324-330.
2. Banerjee A., Moyo S., Salaniponi F., Harries A. HIV testing and tuberculosis treatment outcome in a rural district in Malawi. Trans. R. Soc. Trop. Med. Hyg. 1997, 91:707-708.
3. Girardi E., Palmieri F., Cingolani A., et al. Changing clinical presentation and survival in HIV-associated tuberculosis after highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 2001, 26:326-331.
4. Manosuthi W., Chottanapand S., Thongyen S., Chaovavanich A., Sungkanuparph S. Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 2006, 43:42-46.
5. Maruza M., Albuquerque M.F., Coimbra I., et al. Risk factors for default from tuberculosis treatment in HIV-infected individuals in the state of Pernambuco, Brazil: a prospective cohort study. BMC Infect. Dis. 2011, 11:351.
6. Mehta S.H., Astemborski J., Sterling T.R., Thomas D.L., Vlahov D. Serum albumin as a prognostic indicator for HIV disease progression. AIDS Res. Hum. Retroviruses 2006, 22:14-21.
7. Ministry of Health Malaysia Global AIDS Response 2012: Country Progress Report 2012, 110. (Retrieved from http://www.moh.gov.my/images/gallery/Report/GLOBAL_AIDS_Endorsed_DG.pdf).
8. Nissapatorn V., Kuppusamy I., Sim B.L.H., Quek K.F., Khairul Anuar A. Tuberculosis in HIV/AIDS patients: a Malaysian experience. Southeast Asian J. Trop. Med. Public Health 2005, 36(4):946-953.
9. Quy H.T., Cobelens F.G.J., Lan N.T.N., Buu T.N., Lambregts C.S.B., Borgdorff M.W. Treatment outcomes by drug resistance and HIV status among tuberculosis patients in Ho Chi Minh City, Vietnam. Int. J. Tuberc. Lung Dis. 2006, 10:45-51.
10. Ruiz-Navarro M.D., Espinosa J.A., Hernandez M.J., et al. Effects of HIV status and other variables on the outcome of tuberculosis treatment in Spain. Arch. Bronconeumol. 2005, 41:363-370.
11. Sanguanwongse N.M.D., Cain K.P.M.D., Suriya P.M.S., et al. Antiretroviral therapy for HIV-infected tuberculosis patients save lives but needs to be used more frequently in Thailand. J. Acquir. Immune Defic. Syndr. 2008, 48:181-189.
12. Shah S., Smith C.J., Lampe F., et al. Haemoglobin and albumin as markers of HIV disease progression in the Highly Active Antiretroviral Therapy Era: relationships with gender. HIV Med. 2007, 8:38-45.
13. Sungkanuparph S., Eampokalap B., Chottanapund S., Thongyen S., Manosuthi W. Impact of drug-resistant tuberculosis on the survival of HIV-infected patients. Int. J. Tuberc. Lung Dis. 2007, 11:325-330.
14. Varma J.K., Nateniyom S., Akksilp S., et al. HIV care and treatment factors associated with improved survival during TB treatment in Thailand: an observational study. BMC Infect. Dis. 2009, 9:42.
15. Vasankari T., Holmström P., Ollgren J., Liippo K., Kokki M., Ruutu P. Risk factors for poor tuberculosis treatment outcome in Finland: a cohort study. BMC Publ. Health 2007, 7:291.
16. Velasco M.M.D.P., Castilla V.M.D.P., Sanz J.M.D.P., et al. Effect of simultaneous use of Highly Active Antiretroviral Therapy on survival of HIV patients with tuberculosis. J. Acquir. Immune Defic. Syndr. 2009, 50:148-152.
17. Vijay S., Kumar P., Chauhan L.S., Rao S.V., Vaidyanathan P. Treatment outcome and mortality at one and half year follow-up of HIV infected TB patients under TB control programme in a district of South India. PLoS One 2011, 6:E21008.
18. WHO A Revised Framework to Address TB-HIV Co-infection in the Western Pacific Region 2008, World Health Organization, Geneva, Switzerland.
19. WHO Tuberculosis and HIV Available, (Accessed June 2012). http://www.who.int/hiv/topics/tb/en/index.html.
20. Wobeser W., Yuan L., Naus M. Outcome of pulmonary tuberculosis treatment in the tertiary care setting-Toronto 1992/93. Tuberculosis Treatment Completion Study Group. CMAJ 1999, 160:789-794.